영상 유도 치료 시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Image-guided Therapy Systems Market size is expected to reach USD 9.82 Billion in 2034 from USD 5.88 Billion (2025) growing at a CAGR of 5.87% during 2026-2034.

The Global Image-guided Therapy Systems Market is growing rapidly as advanced imaging technologies transform modern medical procedures. Image-guided therapy systems enable physicians to perform minimally invasive procedures with greater accuracy by providing real-time visualization of internal body structures. These systems are widely used in oncology, cardiology, neurology, and orthopedic procedures.

Technological innovations in imaging modalities such as CT, MRI, ultrasound, and fluoroscopy are driving the adoption of image-guided therapy systems. These technologies help physicians perform complex interventions with improved precision and reduced risk of complications. Hospitals and specialized medical centers are increasingly investing in advanced imaging systems to enhance surgical outcomes and improve patient safety.

The future of the Global Image-guided Therapy Systems Market looks promising as minimally invasive procedures continue to gain popularity. Manufacturers are focusing on developing integrated imaging platforms that combine multiple technologies to provide comprehensive clinical insights. With growing healthcare investments and advancements in medical imaging technologies, the market is expected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Computed Tomography (CT) Scanners
• Ultrasound Systems
• Magnetic Resonance Imaging (MRI)
• Endoscope
• X-ray Fluoroscopy
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)

By Connectivity Technology

• Cardiac Surgery
• Neurosurgery
• Orthopedic Surgery
• Urology
• Gastroenterology
• Oncology Surgery
• Others

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research & Academic Institutes

COMPANIES PROFILED

• Koninklijke Philips NV, Medtronic, Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems Inc, Brainlab AG, Olympus Corporation, Stryker, Canon Medical Systems Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Computed Tomography (CT) Scanners Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Ultrasound Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Magnetic Resonance Imaging (MRI) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Endoscope Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. X-ray Fluoroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Positron Emission Tomography (PET) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Single Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY CONNECTIVITY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Connectivity Technology
• 5.2. Cardiac Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Urology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Oncology Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMAGE-GUIDED THERAPY SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Connectivity Technology
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Connectivity Technology
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Connectivity Technology
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Connectivity Technology
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Connectivity Technology
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMAGE-GUIDED THERAPY SYSTEMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Koninklijke Philips N.V
  • 9.2.2 Medtronic
  • 9.2.3 Siemens Healthineers
  • 9.2.4 Analogic Corporation
  • 9.2.5 GE Healthcare
  • 9.2.6 Varian Medical Systems Inc
  • 9.2.7 Brainlab AG
  • 9.2.8 Olympus Corporation
  • 9.2.9 Stryker
  • 9.2.10 Canon Medical Systems Corporation